The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin

Acta Diabetologica

Volumn 33, Issue 1, 1996, Pages 35-40

  Stefek, M ^a   Drozdikova, I ^a   Vajdova, K ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Diabetic complications; Protein glycation; Stobadine

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIOXIDANT; BOVINE SERUM ALBUMIN; CARBOLINE DERIVATIVE; COPPER ION; FERROUS ION; GLUCOSE; OXYGEN; SODIUM ION; STOBADINE;

ARTICLE; CHROMATOPHORE; DIABETES MELLITUS; DRUG STRUCTURE; FLUORESCENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

ANIMALS; ANTIOXIDANTS; CARBOLINES; CATTLE; COPPER; GLUCOSE; KINETICS; MOLECULAR STRUCTURE; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0029928812     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00571938     Document Type: Article

References (41)

1. Brovnlee M, Glycation of macromolecules. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes mellitus, Wiley, Chichester, pp 669-684, 1992
2. Baynes JW, Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
3. Wolff SP, Jiang ZY, Hunt JV, Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339-352, 1991
4. Hunt JV, Bottoms MA, Mitchinson MJ, Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J 291:529-535, 1993
5. Fu MX, Wells-Knecht KJ, Thorpe SR, Baynes JW, Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 41(Suppl 2):42-48, 1992
6. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW, Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanism, and inhibition of late stages of the Maillard reaction. Diabetes 43:676-683, 1994
7. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW, Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34:3702-3709, 1995
8. Grandhee SK, Monnier VM, Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 266:11649-11653, 1991
9. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW, Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem 266:11654-11660, 1991
10. Oddetti P, Fogarty J, Sell DR, Monnier VM, Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-160, 1992
11. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM, Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286-1292, 1992
12. Beisswenger PJ, Moore LL, Brick-Johnsen T, Curphey TJ, Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
13. Sell DR, Carlson EC, Monnier VM, Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerulal basement membrane. Diabeteologia 36:936-941, 1993
14. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, Lyons TJ, Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
15. Takahashi M, Ohishi T, Aoshima H, Kawana K, Kushida K, Inoue T, Horiuchi K, The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 36:664-667, 1993
16. Hunt JV, Dean RT, Wolff SP, Hydroxyl radical production and autoxidative glycosylation. Biochem J 256:205-212, 1988
17. Giugliano D, Ceriello A, Paolisso G, Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44:363-368, 1995
18. Maxwell SRJ, Prospects for the use of antioxidant therapies. Drugs 49: 345-361, 1995
19. Jahodnik I, Stefek M, Stobadine - an inhibitor of oxidative damage of proteins. Cs Physiol 42:147, 1993
20. Horakova L, Sies H, Steenken S, Antioxidant action of stobadine. In: Packer L (ed) Methods in enzymology. Vol 234. Academic Press, London, pp 572-580, 1994
21. Wolff SP, Dean RT, Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J 245:243-250, 1987
22. Furth AJ, Methods for assaying nonenzymatic glycosylation. Anal Biochem 175:347-360, 1988
23. Sakurai T, Takahashi H, Tsuchiya S, New fluorescence of non-enzymatically glucosylated serum albumin. FEBS Lett 176:27-31, 1984
24. Smith PC, Wang C, Nonenzymatic glycation of albumin by acyl glucuronides in vitro. Comparison of reactions with reducing sugars. Biochem Pharmacol 44:1661-1668, 1992
25. Brownlee M, Glycation and diabetic complications. Diabetes 43:836-841, 1994
26. Marx G, Chevion M, Site-specific modification of albumin by free radicals. Reactions with copper II and ascorbate. Biochem J 236:397-400, 1986
27. Carter DC, Ho JX, Structure of serum albumin. Adv Prot Chem 45:153-203, 1994
28. Chace KV, Carubelli R, Nordquist RE, The role of nonenzymatic glycosylation, transition metals and free radicals in the formation of collagen aggregates. Arch Biochem Biophys 288:473-480, 1991
29. Stasko A, Ondrias K, Misik V, Szocsova H, Gergel D, Stobadine - a novel scavenger of free radicals. Chem Papers 44:493-500, 1990
30. Steenken S, Sundquist AR, Jovanovic SV, Crockett R, Sies H, Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen. Chem Res Toxicol 5:355-360, 1992
31. Stefek M, Benes L, Pyridoindole stobadine is a potent scavenger of hydroxyl radicals. FEBS Lett 294:264-266, 1991
32. Stefek M, Masarykova M, Benes L, Inhibition of cumene hydroperoxide-induced lipid peroxidation by a novel pyridoindole antioxidant in rat liver microsomes. Pharmacol Toxicol 70:407-411, 1992
33. Stefek M, Trnkova Z, Inhibition of alloxan-induced hyperglycaemia in mice by the pyridoindole stobadine. Pharmacol Toxicol 77.320-322, 1995
34. Kagan VE, Tsuchiya M, Serbinova E, Packer L, Sies H, Interaction of the pyridoindole stobadine with peroxyl, Superoxide and chromanoxyl radicals. Biochem Pharmacol 45:393-400, 1993
35. Horakova L, Briviba K, Sies H, Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. Chem Biol Interact 83:85-93, 1992
36. Kallay Z, Bittererova J, Brejcha A, Faberova V, Bezek S, Trnovec T, Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2.3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido[4, 3b] indole dihydrochloride in rats. Arzneimittelforschung 40 (II):974-979, 1990
37. Stefek M, Benes L, Kocis P, Biotransformation of stobadine in vivo. Cs Physiol 35:367, 1986
38. Stefek M, Benes L, Jergelova M, Scasnar V, Turi-Nagy L, Kocis P, Biotransformation of stobadine in rat liver microsomes. Xenobiotica 17:1067-1073, 1987
39. Stefek M, Benes L, Zelnik V, N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase. Xenobiotica 19:143-150, 1989
40. Gajdosikova A, Ujhazy E, Gajdosik A, Chalupa I, Blasko M, Tomaskova A, Liska J, Dubovicky M, Bauer V, Chronic toxicity and micronucleus assay of the new cardroprotective agent stobadine in rats. Arzneimittelforschung 45 (I):531-536, 1995
41. Ujhazy E, Dubovicky M, Balonova T, Jansak J, Zeljenkova D, Teratological assessment of stobadine after single and repeated administration in mice. J Appl. Toxicol 14:357-363, 1994